ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis
FRA:ABL • US0028241000
94.34 EUR
-0.22 (-0.23%)
Last: Feb 16, 2026, 05:28 PM
Overall ABL gets a fundamental rating of 6 out of 10. We evaluated ABL against 65 industry peers in the Health Care Equipment & Supplies industry. ABL scores excellent on profitability, but there are some minor concerns on its financial health. ABL has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- ABL had positive earnings in the past year.
- In the past year ABL had a positive cash flow from operations.
- Each year in the past 5 years ABL has been profitable.
- Of the past 5 years ABL 4 years had a positive operating cash flow.
1.2 Ratios
- ABL has a better Return On Assets (16.60%) than 95.38% of its industry peers.
- ABL has a better Return On Equity (27.43%) than 95.38% of its industry peers.
- With a decent Return On Invested Capital value of 8.88%, ABL is doing good in the industry, outperforming 75.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROIC | 8.88% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ABL has a better Profit Margin (31.88%) than 100.00% of its industry peers.
- In the last couple of years the Profit Margin of ABL has grown nicely.
- Looking at the Operating Margin, with a value of 18.29%, ABL is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
- In the last couple of years the Operating Margin of ABL has grown nicely.
- ABL's Gross Margin of 56.19% is in line compared to the rest of the industry. ABL outperforms 52.31% of its industry peers.
- In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% |
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
2. Health
2.1 Basic Checks
- ABL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- There is no outstanding debt for ABL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- ABL has an Altman-Z score of 5.32. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 5.32, ABL belongs to the best of the industry, outperforming 86.15% of the companies in the same industry.
- The Debt to FCF ratio of ABL is 1.87, which is an excellent value as it means it would take ABL, only 1.87 years of fcf income to pay off all of its debts.
- ABL's Debt to FCF ratio of 1.87 is fine compared to the rest of the industry. ABL outperforms 78.46% of its industry peers.
- ABL has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
- ABL has a better Debt to Equity ratio (0.23) than 67.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Altman-Z | 5.32 |
ROIC/WACC0.9
WACC9.88%
2.3 Liquidity
- ABL has a Current Ratio of 1.70. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of ABL (1.70) is comparable to the rest of the industry.
- ABL has a Quick Ratio of 1.24. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of ABL (1.24) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
- ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
- Measured over the past 5 years, ABL shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
- Looking at the last year, ABL shows a small growth in Revenue. The Revenue has grown by 5.67% in the last year.
- ABL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.08% yearly.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
3.2 Future
- Based on estimates for the next years, ABL will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.38% on average per year.
- ABL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.06% yearly.
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue Next Year7%
Revenue Next 2Y7.2%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 21.74 indicates a rather expensive valuation of ABL.
- Based on the Price/Earnings ratio, ABL is valued a bit cheaper than 70.77% of the companies in the same industry.
- ABL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.19.
- Based on the Price/Forward Earnings ratio of 19.49, the valuation of ABL can be described as rather expensive.
- The rest of the industry has a similar Price/Forward Earnings ratio as ABL.
- ABL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.06.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.74 | ||
| Fwd PE | 19.49 |
4.2 Price Multiples
- ABL's Enterprise Value to EBITDA is on the same level as the industry average.
- Based on the Price/Free Cash Flow ratio, ABL is valued a bit cheaper than the industry average as 61.54% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.13 | ||
| EV/EBITDA | 17.94 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The decent profitability rating of ABL may justify a higher PE ratio.
PEG (NY)1.89
PEG (5Y)3.05
EPS Next 2Y10.76%
EPS Next 3Y10.33%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 2.26%, ABL has a reasonable but not impressive dividend return.
- ABL's Dividend Yield is a higher than the industry average which is at 1.11.
- ABL's Dividend Yield is a higher than the S&P500 average which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.26% |
5.2 History
- On average, the dividend of ABL grows each year by 11.40%, which is quite nice.
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
- ABL pays out 28.93% of its income as dividend. This is a sustainable payout ratio.
- ABL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
FRA:ABL (2/16/2026, 5:28:15 PM)
94.34
-0.22 (-0.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22 2026-01-22/bmo
Earnings (Next)04-14 2026-04-14/bmo
Inst Owners81.33%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap164.04B
Revenue(TTM)44.33B
Net Income(TTM)13.98B
Analysts80
Price Target115.93 (22.89%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.26% |
Yearly Dividend1.87
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)-6.91%
PT rev (3m)-8.5%
EPS NQ rev (1m)-0.01%
EPS NQ rev (3m)-0.04%
EPS NY rev (1m)0.16%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)-0.91%
Revenue NY rev (3m)-0.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.74 | ||
| Fwd PE | 19.49 | ||
| P/S | 4.44 | ||
| P/FCF | 28.13 | ||
| P/OCF | 21.34 | ||
| P/B | 3.82 | ||
| P/tB | 9.1 | ||
| EV/EBITDA | 17.94 |
EPS(TTM)4.34
EY4.6%
EPS(NY)4.84
Fwd EY5.13%
FCF(TTM)3.35
FCFY3.55%
OCF(TTM)4.42
OCFY4.69%
SpS21.26
BVpS24.7
TBVpS10.37
PEG (NY)1.89
PEG (5Y)3.05
Graham Number49.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROCE | 11.52% | ||
| ROIC | 8.88% | ||
| ROICexc | 9.99% | ||
| ROICexgc | 19.14% | ||
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% | ||
| FCFM | 15.78% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
F-Score8
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Debt/EBITDA | 1.04 | ||
| Cap/Depr | 70.33% | ||
| Cap/Sales | 5.02% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.77% | ||
| Profit Quality | 49.49% | ||
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 5.32 |
F-Score8
WACC9.88%
ROIC/WACC0.9
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year7%
Revenue Next 2Y7.2%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%
EBIT growth 1Y15.18%
EBIT growth 3Y-0.36%
EBIT growth 5Y9.67%
EBIT Next Year25.17%
EBIT Next 3Y13.91%
EBIT Next 5Y13.17%
FCF growth 1Y6.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.48%
OCF growth 3YN/A
OCF growth 5YN/A
ABBOTT LABORATORIES / ABL.DE FAQ
What is the fundamental rating for ABL stock?
ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE.
Can you provide the valuation status for ABBOTT LABORATORIES?
ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.
What is the profitability of ABL stock?
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for ABL stock?
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABL.DE) is 21.74 and the Price/Book (PB) ratio is 3.82.
How sustainable is the dividend of ABBOTT LABORATORIES (ABL.DE) stock?
The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 6 / 10 and the dividend payout ratio is 28.93%.